Real-life prescribing predictors in newly diagnosed COPD patients

Price D, Jones R, Gruffydd-Jones K, Brusselle G, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 24.

By |September 13th, 2016|OPCRD|0 Comments

Step up therapy-prescribing practice and its implications

Turner SW, Richardson K, Burden A, Thomas DM, Murray C, Price D

NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 27.

By |September 13th, 2016|OPCRD|0 Comments

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD

Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WMC, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D

Int J Chron Obstruct Pulmon Dis 2014; 9: 1163-86.

By |September 13th, 2016|OPCRD|0 Comments

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide

Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, King C, Thomas M

J Asthma Allergy 2015; 8: 1-13.

By |September 13th, 2016|OPCRD|0 Comments

Increased dose of inhaled corticosteroid versus add-on long-acting β-agonist for step-up therapy in asthma

Israel E, Roche N, Martin RJ, Colice G, Dorinsky PM, Postma DS, Guilbert TW, van Aalderen WM, Grigg J, Hillyer EV, Burden A, von Ziegenweidt J, Thomas V, Price DB

Ann Am Thorac Soc 2015; 12(6): 798-806.

By |September 13th, 2016|OPCRD|0 Comments

Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study

Turner SW, Richardson K, Burden A, Thomas M, Murray C, Price D

NPJ Prim Care Respir Med 2015; 25: 15041.

By |September 13th, 2016|OPCRD|0 Comments

Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma

van Aalderen WM, Grigg J, Guilbert TW, Roche N, Israel E, Martin RJ, Colice G, Postma DS, Hillyer EV, Burden A, Thomas V, von Ziegenweidt J, Price D

J Allergy Clin Immunol Pract 2015; 3(5): 721-31.e16.

By |September 13th, 2016|OPCRD|0 Comments

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC

Int J Chron Obstruct Pulmon Dis 2015; 10: 2207-17.

By |September 13th, 2016|OPCRD|0 Comments

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study

Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M, Wenzel SE, Wilson AM, Small MB, Gopalan G, Ashton VL, Burden A, Hillyer EV, Kerkhof M, Pavord ID

Lancet Respir Med 2015; 3(11): 849–58.

By |September 13th, 2016|OPCRD|0 Comments

Predicting frequent COPD exacerbations using primary care data

Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB; Respiratory Effectiveness Group

Int J Chron Obstruct Pulmon Dis 2015; 10: 2439-50.

By |September 13th, 2016|OPCRD|0 Comments